Acne 

Actinic Keratosis 

Aesthetics

Alopecia

Biologic Treatments for Moderate to Severe Atopic Dermatitis 

Atopic Dermatitis 

COVID-19

Chronic Hand Eczema

Drug Watch

Eczema

General Dermatology 

Hidradenitis Suppurativa

Melasma

NP and PA

Pediatric Dermatology

Pigmentary Disorders 

Practice Management 

Precision Medicine and Biologics

Prurigo Nodularis

Emerging Therapies Plaque Psoriasis

Treatments for Plaque Psoriasis 

Psoriasis 

Psoriatic Arthritis 

Rare Disease

Rosacea 

Skin Cancer (Nonmelanoma)

Skin Cancer

Vitiligo

Wound Care

News

Media

Around the Practice

Between The Lines

Case-Based Peer Perspective

Clinical Case Collective

DermView

Expert Perspectives

Fellows Face Off

Frontline Forum

Medical World News

Patient Perspectives

Podcasts

Readout360

Recognize and Refer

Conferences

Conference Coverage

Conference Listing

Events

Case-Based Roundtable

Publication

Dermatology Times

CME/CE

Resources

DermIQ

Interactive Tools

Job Board

Partner Perspectives

Polls

Editorial Advisory Board

Partners

Subscribe

Maddi Hebebrand is an associate editor of 

and joined the MJH Life Sciences team in May 2024. She attended Baldwin Wallace University, studying Media Production and Film, and is now finishing her Masters in Digital Media through Ohio University. When she's not writing, Maddi loves to read, attend concerts and spend time with her family.

Articles

Melinda Gooderham, MSc, MD, FRCPC, emphasized the significance of the study’s results, showcasing stable laboratory parameters over a 12-week trial.

Phase 2b Trial Reinforces Zasocitinib’s Safety Profile

In a Dermatology Times Case-Based Roundtable event, Hilary Baldwin, MD, shared pearls for challenging acne cases.

Addressing Challenging Cases of Acne: Part 1

Kaitlyn Bader is the assistant managing editor of 

 and joined the MJH Life Sciences team in June 2022. She attended Otterbein University in Westerville, Ohio, and earned a Bachelor of Arts degree in literary studies with minors in creative writing and film studies. Prior to health care news, Kaitlyn worked in industrial marketing. She enjoys cooking, reading, and tending to her house plants.

This week’s collection of the latest dermatologic studies includes the potential association between hidradenitis suppurativa and infertility, refractory pediatric atopic dermatitis treated with dupilumab and abrocitinib, and omalizumab's efficacy in chronic inducible urticaria.

Journal Digest: October 8

and joined the MJH Life Sciences team in February 2023. She attended Kent State University and earned a Bachelor of Science degree in journalism with minors in public relations and creative writing. She enjoys making and listening to music, reading, and spending time with her cats, Astrid and Marceline.

Light delves into the science behind the new peer-reviewed data assessing benzene presence and formation in benzoyl peroxide products.

Valisure's David Light Shares Insights Into Newly-Published Benzene and BPO Data

About

Advertise

Contact Us

Do Not Sell My Information

Terms and Conditions

Privacy Policy

Dermatology Times and Multimedia Medical, LLC

Twitter

Facebook

Linkedin

Topics

Acne

Pigmentary Disorders

Practice Management

Psoriasis

Psoriatic Arthritis

Rosacea

1rem

clinical

Clinical

Shailender Bhatia, MD; Omid Hamid, MD; Sapna Patel, MD; Ryan J. Sullivan, MD; Jeffrey S. Weber, MD, PhD

Community Practice Connections™: 19th Annual International Symposium on Melanoma and Other Cutaneous Malignancies® 

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

Victoria Maloney, PA-C; Renata Block, MSS, PA-C; Tomas Chao, MPAS, PA-C

Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)

Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia

Dermalorian™ Webinar Series on Moderate to Severe Atopic Dermatitis

21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

Emma Guttman-Yassky, MD, PhD; Linda Stein Gold, MD 

Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis

Raj Chovatiya, MD, PhD, MSCI, FAAD; Jason E. Hawkes, MD, MS, FAAD; Martina Porter, MD

Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making

Milan J. Anadkat, MD; Arash Mostaghimi, MD, MPA, MPH

Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis

Milan J. Anadkat, MD; Johann E. Gudjonsson MD, PhD; Robert G. Micheletti, MD

Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis

Andrew Alexis, MD, MPH; Lakshi M. Aldredge, MSN, ANP-BC, DCNP

Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color

Tina Bhutani, MD, MAS, FAAD; Rajal Patel, MD

Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach